Regulation of Alternative Splicing in B-Cell ALL By DYRK1A

被引：0
|
作者：
Jin, Qi [1 ]
Harris, Ethan [1 ]
Myers, Jacquelyn A. [2 ]
Cotton, Anitria [3 ]
Wen, Jeremy [3 ]
Melo-Cardenas, Johanna [1 ]
Yoshimi, Akihide [4 ]
Abdel-Wahab, Omar [5 ]
Obeng, Esther A. [2 ]
Crispino, John D. [3 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN USA
[2] St Jude Childrens Res Hosp, Oncol, Memphis, TN USA
[3] St Jude Childrens Res Hosp, Div Expt Hematol, Memphis, TN USA
[4] Natl Canc Ctr, Tokyo, Japan
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174923
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] RBFOX2 and alternative splicing in B-cell lymphoma
    Hilmar Quentmeier
    Claudia Pommerenke
    Stephan H. Bernhart
    Wilhelm G. Dirks
    Vivien Hauer
    Steve Hoffmann
    Stefan Nagel
    Reiner Siebert
    Cord C. Uphoff
    Margarete Zaborski
    Hans G. Drexler
    Blood Cancer Journal, 8
  • [22] Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
    Marco Papenfuss
    Svenja Lützow
    Gerrit Wilms
    Aaron Babendreyer
    Maren Flaßhoff
    Conrad Kunick
    Walter Becker
    Scientific Reports, 12
  • [23] Regulation of Dyrk1A kinase activity by 14-3-3
    Kim, D
    Won, J
    Shin, DW
    Kang, J
    Kim, YJ
    Choi, SY
    Hwang, MK
    Jeong, BW
    Kim, GS
    Joe, CO
    Chung, SH
    Song, WJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 323 (02) : 499 - 504
  • [24] DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
    Kumar, Kunal
    Suebsuwong, Chalada
    Wang, Peng
    Garcia-Ocana, Adolfo
    Stewart, Andrew F.
    DeVita, Robert J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (06) : 2901 - 2922
  • [25] Ultraselective DYRK1A/B Inhibitors Mediated β-Cell Proliferation and Insulin Production In Vitro and In Vivo
    Mittapalli, Gopi Kumar
    Mak, Chi-Ching
    Bossard, Carine
    Vakiti, Ramkrishna Reddy
    Creger, Emily
    Gutierrez, Erik
    Horsley, Erich A.
    Swearingen, Christopher
    Hill, John S.
    DIABETES, 2024, 73
  • [26] Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B
    Segretti, Natanael D.
    Takarada, Jessica E.
    Ferreira, Marcos A., Jr.
    Santiago, Andre da Silva
    Teodoro, Bruno V. M.
    Damiao, Mariana C. F. C. B.
    Godoi, Paulo H.
    Cunha, Micael R.
    Fala, Angela M.
    Ramos, Priscila Z.
    Ishikawa, Eloisa E.
    Mascarello, Alessandra
    Serafim, Ricardo A. M.
    Azevedo, Hatylas
    Guimaraes, Cristiano R. W.
    Counago, Rafael M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 68
  • [27] DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1
    Guo, Xiumei
    Williams, Jason G.
    Schug, Thaddeus T.
    Li, Xiaoling
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (17) : 13223 - 13232
  • [28] DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly
    Alvarez, M
    Estivill, X
    de la Luna, S
    JOURNAL OF CELL SCIENCE, 2003, 116 (15) : 3099 - 3107
  • [29] Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
    Toiber, Debra
    Azkona, Garikoitz
    Ben-Ari, Shani
    Toran, Nuria
    Soreq, Hermona
    Dierssen, Mara
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 348 - 359
  • [30] Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation
    Ines H. Kaltheuner
    Kanchan Anand
    Jonas Moecking
    Robert Düster
    Jinhua Wang
    Nathanael S. Gray
    Matthias Geyer
    Nature Communications, 12
12345